LLY

720.79

+0.42%↑

JNJ

153.37

+0.64%↑

ABBV

185.36

+1.38%↑

UNH

298.13

+0.31%↑

ABT

132.76

+0.59%↑

LLY

720.79

+0.42%↑

JNJ

153.37

+0.64%↑

ABBV

185.36

+1.38%↑

UNH

298.13

+0.31%↑

ABT

132.76

+0.59%↑

LLY

720.79

+0.42%↑

JNJ

153.37

+0.64%↑

ABBV

185.36

+1.38%↑

UNH

298.13

+0.31%↑

ABT

132.76

+0.59%↑

LLY

720.79

+0.42%↑

JNJ

153.37

+0.64%↑

ABBV

185.36

+1.38%↑

UNH

298.13

+0.31%↑

ABT

132.76

+0.59%↑

LLY

720.79

+0.42%↑

JNJ

153.37

+0.64%↑

ABBV

185.36

+1.38%↑

UNH

298.13

+0.31%↑

ABT

132.76

+0.59%↑

Search

Novo Nordisk A-S

Fechado

SetorSaúde

69.45 1.17

Visão Geral

Variação de preço das ações

24h

Atual

Mín

68.29

Máximo

69.49

Indicadores-chave

By Trading Economics

Rendimento

804M

29B

Vendas

-7.6B

78B

P/E

Médio do Setor

18.919

53.54

EPS

6.53

Rendimento de Dividendos

2.4

Margem de lucro

37.182

Funcionários

77,406

EBITDA

5.9B

46B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+31.1% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.40%

2.44%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

46B

312B

Abertura anterior

68.28

Fecho anterior

69.45

Sentimento de Notícias

By Acuity

8%

92%

8 / 381 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Novo Nordisk A-S Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de mai. de 2025, 11:36 UTC

Principais Notícias

Novo Nordisk CEO to Step Down Amid Market Challenges

12 de mai. de 2025, 09:36 UTC

Grandes Movimentos do Mercado

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

7 de mai. de 2025, 11:29 UTC

Principais Notícias
Ganhos
Grandes Movimentos do Mercado

Novo Nordisk Investors Breathe Sigh of Relief Despite Guidance Hit From Copycat Drugs -- 2nd Update

7 de mai. de 2025, 07:05 UTC

Ganhos

Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales -- Update

7 de mai. de 2025, 06:19 UTC

Ganhos

Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales

29 de mai. de 2025, 01:00 UTC

Principais Notícias

How Ozempic's Maker Lost Its Grip on the Obesity Market It Created -- WSJ

20 de mai. de 2025, 14:08 UTC

Ganhos

Novo Nordisk Woes Weigh on Denmark's Economy. Here's How. -- Barrons.com

20 de mai. de 2025, 07:43 UTC

Conversa de Mercado

Novo Nordisk Guidance at Risk After CEO News -- Market Talk

16 de mai. de 2025, 18:35 UTC

Principais Notícias

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

16 de mai. de 2025, 17:34 UTC

Principais Notícias

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 2nd Update

16 de mai. de 2025, 13:42 UTC

Ações em Alta

Stocks to Watch Friday: Charter, Novo Nordisk, Applied Materials -- WSJ

16 de mai. de 2025, 13:27 UTC

Conversa de Mercado

Novo Nordisk CEO Departure Comes as a Surprise -- Market Talk

16 de mai. de 2025, 13:15 UTC

Principais Notícias

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- Update

16 de mai. de 2025, 12:17 UTC

Ganhos

Novo Nordisk Chairman: No Link Between CEO Change and Other Recent Exec Departures

12 de mai. de 2025, 22:14 UTC

Principais Notícias

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 de mai. de 2025, 18:45 UTC

Principais Notícias

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

12 de mai. de 2025, 12:07 UTC

Conversa de Mercado

Trump's Drug Price Cap Plan Is 'Alarming' for Pharma Sector -- Market Talk

12 de mai. de 2025, 07:20 UTC

Conversa de Mercado

Pharma Shares Face Risks From Trump's Pricing Plans -- Market Talk

7 de mai. de 2025, 15:13 UTC

Ganhos

These Stocks Are Moving the Most Today: Super Micro, AMD, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More -- Barrons.com

7 de mai. de 2025, 13:56 UTC

Ganhos

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

7 de mai. de 2025, 13:45 UTC

Ganhos

These Stocks Are Moving the Most Today: Super Micro, AMD, Marvell, Disney, Uber, Nordisk, Sarepta, EA, Upstart, and More -- Barrons.com

7 de mai. de 2025, 11:25 UTC

Ganhos

These Stocks Are Moving the Most Today: Super Micro, AMD, Disney, Uber, Novo Nordisk, Sarepta, EA, Tesla, and More -- Barrons.com

7 de mai. de 2025, 11:18 UTC

Ganhos

Novo Nordisk Stock Jumps After Earnings. It Cuts Guidance as Weight-Loss Drug Sales Slow. -- Barrons.com

7 de mai. de 2025, 09:55 UTC

Ganhos

These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Disney, and More -- Barrons.com

7 de mai. de 2025, 09:36 UTC

Ganhos

These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Tesla, and More -- Barrons.com

7 de mai. de 2025, 09:04 UTC

Ganhos
Ações em Alta

Stocks to Watch Wednesday: Disney, Uber, Super Micro -- WSJ

7 de mai. de 2025, 08:10 UTC

Conversa de Mercado

Novo Nordisk Cuts Guidance Slightly More Than Expected -- Market Talk

7 de mai. de 2025, 08:08 UTC

Conversa de Mercado

Novo Nordisk's Downgraded Guidance Assumes Large Wegovy Uplift in 2H -- Market Talk

7 de mai. de 2025, 07:11 UTC

Conversa de Mercado
Ganhos

Novo Nordisk Shares Seen Under Pressure After Downgrade -- Market Talk

7 de mai. de 2025, 05:39 UTC

Ganhos

Novo Nordisk: Sales Outlook Assumes Reduction in Patients on Compounded GLP-1 Treatments During 2H25

Comparação entre Pares

Variação de preço

Novo Nordisk A-S Previsão

Preço-alvo

By TipRanks

31.1% parte superior

Previsão para 12 meses

Média 92.35 USD  31.1%

Máximo 138.123 USD

Mínimo 61 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Novo Nordisk A-S - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

9 ratings

3

Comprar

5

Manter

1

Vender

Pontuação Técnica

By Trading Central

62.63 / 69.23Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

8 / 381 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Novo Nordisk A-S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.